Abstract:ObjectiveTo examine the early outcomes, associated factors and predictive values of clinical outcomes of different tandospirone doses in patients with a generalized anxiety disorder (GAD).MethodsThis was a posthoc analysis of "a randomized, controlled multicenter clinical trial of the efficacy and safety of different doses of tandospirone on GAD". A total of 274 patients with GAD were included and randomized into the high-dose (tandospirone 60 mg/d) and low-dose (tandospirone 30 mg/d) groups for a 6-week treatment. The Hamilton Anxiety (HAMA), Clinical Global Impression-Severity (CGI-S), Short-Form-12 (SF-12) scales were used for assessment. The trial was registered at clinical trail.gov (NCT01614041).Results(1) In the first week of treatment, 35.8% of patients in the high-dose group fulfilled the early onset criteria, which was significantly higher than 19.0% found in the low-dose group (p = 0.002). In the second week of treatment, 22.6% of patients in the high-dose group achieved an early response, versus 12.4% in the low-dose group, indicating a significant difference (p = .026). (2) Factors associated with early onset at week 1 included baseline HAMA total score (OR = 0.916, 95%CI 0.882-0.952), age (OR = 0.974, 95%CI 0.950-0.998), drug dose (30 mg vs. 60 mg; OR = 0.298, 95%CI 0.156-0.568) and SF-12 physiological total score (OR = 1.030, 95%CI 1.010-1.050). (3) Early onset was significantly associated with response rate (OR = 18.34, 95%CI 12.10-27.81), remarkable response rate (OR = 27.56, 95%CI 11.65-65.17) and recovery rate (OR = 11.85, 95%CI 4.98-28.18). Group (high dose group vs. low dose group) (chi(2) = 8.535, p = .003) and baseline HAMA total score (chi(2) = 70.840, p < .001) were independent predictors of onset time.ConclusionsThe early outcomes of high-dose tandospirone in the treatment of GAD are better than those of the low-dose group. Patients with younger age at onset, milder anxiety symptoms and better physiological functions administered high-dose tandospirone showed rapid onset, great early outcomes, high recovery rate and good prognosis. Drug onset time had a good predictive effect on treatment outcome.

Clinical Efficacy of Tandospirone in Adolescents with Anxiety Pre-examination: a Randomized Controlled Trial

Clinical Evaluation of the Efficacy and Safety of Tandospirone Versus Sertraline Monotherapy for Social Anxiety Disorder: a Randomized Open‐label Trial

Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial

Effects of Tandospirone Augmentation in Major Depressive Disorder Patients with High Anxiety: A Multicenter, Randomized, Parallel-Controlled, Open-Label Study

Comparison study on effectiveness and safety of tandospirone and buspirone in the treatment general anxiety disorders

Effectiveness of tandospirone in treatment of patients with general anxiety disorder and its impact on quality of life: a multicenter open study

Possible Sertraline-Induced Extrapyramidal Adverse Effects in an Adolescent.

A comparison study of sertraline,venlafxin and alprazolam in treatment of generalized anxiety disorder

Early Outcomes, Associated Factors and Predictive Values of Clinical Outcomes of Tandospirone in Generalized Anxiety Disorder: a Post-Hoc Analysis of a Randomized, Controlled, Multicenter Clinical Trial

Escitalopram and sertraline in treatment of depression with anxiety

Comparison of tandospirone and escitalopram as a symptomatic treatment in Multiple System Atrophy-cerebellar ataxia: An open-label, non-controlled, 4 weeks observational study

Therapeutic effect of tandospirone on irritable bowel syndrome-diarrhea complicated with anxiety

Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study

Targeted Sleep Enhancement Reduces Residual Anxiety Symptoms in Peri-Adolescents Previously Treated for Anxiety Disorders

Child/Adolescent Anxiety Multimodal Study: Evaluating Safety

Bupropion SR in the treatment of depression comorbid with anxiety:a randomized,double-blind clinical trial

A randomized controlled pilot trial of vilazodone for adult separation anxiety disorder

Sleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents

A Preliminary Study of Different Treatment Strategies for Anxious Depression.

Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open‐labeled randomized control trial

Lack of Acute Agomelatine Effect in a Model of Social Anxiety in Healthy Volunteers: A Double-Blind, Placebo-Controlled Trial